MB, P., K, K., M, C., WA, K., A, S., C, S., . . . MT, M. (2021). Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nature cancer, 2(10), 1002.
Chicago Style (17th ed.) CitationMB, Pappalardi, et al. "Discovery of a First-in-class Reversible DNMT1-selective Inhibitor with Improved Tolerability and Efficacy in Acute Myeloid Leukemia." Nature Cancer 2, no. 10 (2021): 1002.
MLA (9th ed.) CitationMB, Pappalardi, et al. "Discovery of a First-in-class Reversible DNMT1-selective Inhibitor with Improved Tolerability and Efficacy in Acute Myeloid Leukemia." Nature Cancer, vol. 2, no. 10, 2021, p. 1002.
Warning: These citations may not always be 100% accurate.
